We are live on ! Find out more
CCCC icon

C4 Therapeutics
CCCC

119 hedge funds and large institutions have $1.15B invested in C4 Therapeutics in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

27% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 33

5% more funds holding

Funds holding: 113 → 119 (+6)

2.62% more ownership

Funds ownership: 71.19% → 73.81% (+2.6%)

25% less capital invested

Capital invested by funds: $1.54B → $1.15B (-$388M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
119
Holders Change
+6
Holders Change %
+5.31%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
22
Increased
42
Reduced
33
Closed
16
Calls
$1.9M
Puts
–
Net Calls
+$1.9M
Net Calls Change
-$2.73M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$24.8M
2
Millennium Management
Millennium Management
New York
+$18.4M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$10.3M
4
BlackRock
BlackRock
New York
+$9.84M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$7.32M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$18.1M
2
DCM
Driehaus Capital Management
Illinois
-$11.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$8.94M
4
SCM
Soleus Capital Management
Connecticut
-$7.49M
5
First Trust Advisors
First Trust Advisors
Illinois
-$3.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
101
STRS Ohio
Ohio
$180K – – –
VEA
102
Virtus ETF Advisers
New York
$180K +$21.6K +546 +11%
TRCT
103
Tower Research Capital (TRC)
New York
$155K +$79.2K +2,003 +71%
Zurich Cantonal Bank
104
Zurich Cantonal Bank
Switzerland
$110K +$135K +3,421 New
AIP
105
Ameritas Investment Partners
Nebraska
$95K – – –
PHK
106
Point72 Hong Kong
Hong Kong
$65K +$26.4K +668 +50%
QT
107
Quantbot Technologies
New York
$54K -$79.1K -2,000 -54%
Nisa Investment Advisors
108
Nisa Investment Advisors
Missouri
$40K +$36.8K +930 +135%
MIFH
109
Migdal Insurance & Financial Holdings
Israel
$20K -$23.3K -589 -49%
Group One Trading
110
Group One Trading
Illinois
$16K +$7.91K +200 +67%
LSA
111
Leonteq Securities AG
Switzerland
$15.5K +$19K +480 New
PSB
112
Piscataqua Savings Bank
New Hampshire
$13K – – –
Rockefeller Capital Management
113
Rockefeller Capital Management
New York
$12K – – –
EWM
114
Endurance Wealth Management
Rhode Island
$11K – – –
Daiwa Securities Group
115
Daiwa Securities Group
Japan
$5K +$5.62K +142 New
CT
116
Cambridge Trust
Massachusetts
$3K +$3.96K +100 New
Manulife (Manufacturers Life Insurance)
117
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$646 +$13.9K +352 +2%
FFG
118
Ford Financial Group
California
$1 +$1.98K +50 New
Point72 Asset Management
119
Point72 Asset Management
Connecticut
– -$8.94M -200,000 Closed
First Trust Advisors
120
First Trust Advisors
Illinois
– -$3.88M -86,952 Closed
PAWC
121
P.A.W. Capital
Connecticut
– -$1.79M -40,000 Closed
GGHC
122
Gilder Gagnon Howe & Co
New York
– -$1.76M -39,506 Closed
Prudential Financial
123
Prudential Financial
New Jersey
– -$1.04M -23,270 Closed
Two Sigma Investments
124
Two Sigma Investments
New York
– -$942K -21,073 Closed
ACP
125
Acuta Capital Partners
California
– -$938K -21,000 Closed
2 3 4
5
6

CCCC Hedge Fund Activity: Q4 2021 in Review

119 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in C4 Therapeutics (CCCC) for Q4 2021, worth a combined $1.15B — down 25% from $1.54B a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new CCCC positions and 16 closed out — a net gain of 6 holders — while 42 added to existing stakes and 33 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $24.8M. The largest seller was Jennison Associates, cutting an estimated $18.1M.

  • 119 institutional investors held C4 Therapeutics (CCCC) as of Q4 2021, up from 113 in Q3 2021.
  • Funds reported $1.15B of C4 Therapeutics stock for Q4 2021, down 25% quarter-over-quarter.
  • 22 funds opened new C4 Therapeutics positions in Q4 2021 and 16 closed out, a net change of +6 holders.
  • The largest C4 Therapeutics buyer in Q4 2021 was Morgan Stanley, an estimated $24.8M added.
  • The largest C4 Therapeutics seller in Q4 2021 was Jennison Associates, an estimated $18.1M sold.

Based on aggregated 13F filings for Q4 2021.